Tokyo Tape
Sign in

Astellas Pharma

4503.TPharmaceutical
Key numbers · FY ended 2026-03
Revenue¥2.14T+11.9% YoYOperating income¥382.6bn+832.4% YoYNet income (owners)¥291.5bn+474.5% YoYTotal assets¥3.57T+6.8% YoYEPS (basic)¥162.77+474.1% YoY

Full financial history and reports →

Stock price4503 · View chart ↗

Open the price chart on TradingView.

Latest filings
Mon, Apr 27 · JST1 filing
15:36MATERIALAstellas Pharma · Event with a material impact on financial position
Tue, Feb 4 · JST2 filings
15:40MATERIALAstellas Pharma · Event with a material impact on financial position15:39MATERIALAstellas Pharma · Event with a material impact on financial position

All filings →

Major holders (5%+) · 0
HolderStakeChangeFiled

No holder currently reports 5% or more.

Each holder's own ratio from its most recent large-shareholding report.